Ebola laboratory tests: Difference between revisions
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{MJM}}; {{GRN}} | {{CMG}}; {{AE}} {{MJM}}; {{GRN}} | ||
==Overview== | ==Overview== | ||
[[Ebola]] infection is associated with nonspecific laboratory abnormalities including alterations in the [[white blood cell]] count, [[blood]] | [[Ebola]] infection is associated with nonspecific laboratory abnormalities including alterations in the [[white blood cell]] count, [[blood chemistry tests]] and [[liver function tests]], all of which may contribute to a disruption in the [[thrombosis|clotting]] process and bleeding. | ||
==Laboratory Findings== | ==Laboratory Findings== |
Revision as of 16:37, 15 July 2014
Ebola Microchapters |
Diagnosis |
---|
Treatment |
Postmortem Care |
Case Studies |
Ebola laboratory tests On the Web |
American Roentgen Ray Society Images of Ebola laboratory tests |
Risk calculators and risk factors for Ebola laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S.; Guillermo Rodriguez Nava, M.D. [2]
Overview
Ebola infection is associated with nonspecific laboratory abnormalities including alterations in the white blood cell count, blood chemistry tests and liver function tests, all of which may contribute to a disruption in the clotting process and bleeding.
Laboratory Findings
There are no specific laboratory findings of Ebola virus disease. The following table shows some nonspecific findings, including:[1]
Test | Findings |
---|---|
White blood cell count | Leucopenia Lymphopenia Neutrophilia |
Blood smear | Left shift Atypical lymphocytes |
Liver function tests | Raised aspartate aminotransferase Raised alanine aminotransferase Extended prothrombin time Extended partial thromboplastin time |
Proteins | Hyperproteinemia |
Urinalysis | Proteinuria |
References
- ↑ Feldmann H, Geisbert TW (2011). "Ebola haemorrhagic fever". Lancet. 377 (9768): 849–62. doi:10.1016/S0140-6736(10)60667-8. PMC 3406178. PMID 21084112.